Goldman Sachs and KeyBanc are Bullish on Danaher (DHR)

Danaher Corporation (NYSE:DHR) is 1 of the 14 Best Large Cap Stocks to Invest In Now. On December 9, Goldman Sachs started covering Danaher Corporation (NYSE:DHR), giving the banal a Buy standing and mounting the terms people astatine $265.

The probe steadfast pointed to the company’s beardown $6 cardinal bioprocessing franchise. Despite a presently muted instrumentality market, this portion of Danaher Corporation’s (NYSE:DHR) concern is increasing astatine a precocious single-digit rate. Goldman Sachs expects overhangs hurting instrumentality request are starting to easiness and the pharmaceutical manufacture present has a clearer presumption connected funding.

Goldman Sachs besides sees a displacement towards Contract Development and Manufacturing Organization (CDMO) outsourcing to code onshoring. This could boost bioprocessing instrumentality orders successful the adjacent term. The probe steadfast expects Danaher Corporation’s (NYSE:DHR) 2026 Biotechnology integrated maturation astatine 9.2%, which is higher than the statement of 6.1%. This presumption is supported by the firm’s US CDMO survey, wherever 68% of respondents suggested that they program to bargain much instrumentality than past year.

Earlier, connected December 8, KeyBanc Capital Markets highlighted apical picks successful the Life Sciences Tools & Services manufacture for 2026. The probe steadfast cited improved biopharma spending and the easing of argumentation concerns.

KeyBanc Capital Markets noted that aft 3 pugnacious years marked by constricted backing and destocking, the assemblage showed signs of betterment successful Q3 2025 net and large-caps similar Danaher Corporation (NYSE:DHR) led the banal terms recovery.

The steadfast sees Danaher Corporation’s (NYSE:DHR) preliminary 2026 guidance of 3-6% halfway gross maturation arsenic conservative. This presumption is supported by the important summation successful biotech backing successful caller months.

Danaher Corporation (NYSE:DHR) is simply a starring planetary beingness sciences and diagnostics innovation company. The institution is known for its professional, medical, research, and concern products and services that assistance discover, develop, and present life-changing therapies.

While we admit the imaginable of DHR arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 14 Most Promising Fintech Stocks to Invest In and 15 Best Technology Penny Stocks to Buy.

Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.